ADVFN US – Market Content Editor
-
Tesla Sinks as U.S. Stocks Edge Lower Amid Uncertainty Over Trump Tariffs
U.S. stocks slipped on Monday, retreating from last week’s record highs as investors grew wary of President Donald Trump’s looming tariff decisions. As of 09:32 ET, the Dow Jones Industrial Average was down 95 points, or 0.2%, while the S&P 500 fell 22 points, or 0.4%. The NASDAQ Composite dropped 95 points, or 0.5%. All…
-
Uber Shares Soar to Record High of $94.46
Uber Technologies Inc. (NYSE:UBER) has reached a new peak, with its stock climbing to an all-time high of $94.46, pushing the company’s market value close to $196 billion. Over the last 12 months, Uber’s shares have surged more than 31%, signaling strong investor confidence amid the company’s ongoing market strength. With annual revenues hitting $45.4…
-
Dow Jones, S&P, Nasdaq, U.S. Stocks Slip on Trade Uncertainty; Tesla Shares Drop Sharply
U.S. stocks declined Monday amid rising uncertainty over President Donald Trump’s trade tariffs after last week’s record highs. By 9:32 a.m. ET, the Dow Jones fell 95 points (0.2%), the S&P 500 dropped 22 points (0.4%), and the Nasdaq slipped 95 points (0.5%). With the pause on Trump’s reciprocal tariffs nearing expiration and only preliminary…
-
Globalstar Stock Climbs 5% Following Launch Agreement with SpaceX
Globalstar Inc. (NASDAQ:GSAT) shares rose 5% after the telecommunications infrastructure company announced a launch services agreement with SpaceX for its upcoming satellite deployment. Under the deal, Globalstar will use a SpaceX Falcon 9 rocket to launch satellites procured through a 2022 agreement with MDA. The launch is expected next year, following an initial launch scheduled…
-
Ingram Micro Stock Drops 4% Amid Ransomware Attack Disrupting Operations
Ingram Micro Holding Corporation (NYSE:INGM) shares declined 4% in premarket trading after the technology distributor announced it is facing a system outage caused by a ransomware attack targeting certain internal systems. The company has taken swift measures to address the breach, including proactively shutting down affected systems and deploying other mitigation strategies. Ingram Micro is…
-
Artelo Biosciences Stock Soars 114% After Promising Depression Treatment Data
Artelo Biosciences Inc (NASDAQ:ARTL) shares surged 114.2% following the presentation of encouraging preclinical data for its CBD and TMP cocrystal drug candidate, ART12.11, at the 35th Annual International Cannabinoid Research Society Symposium. The clinical-stage pharma company reported that ART12.11 exhibited strong antidepressant-like effects in animal studies, with efficacy comparable to sertraline (Zoloft), a widely prescribed…
-
Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares soared 50% following an amendment to its exchange agreement with Malaysian investment holding company FITTERS Diversified Berhad (KL:9318). The biopharmaceutical firm announced revised terms for its transaction with FITTERS, a company involved in fire safety equipment, waste-to-resource services, and real estate development. Under the updated agreement, Cyclacel will acquire all…
-
Bit Digital Stock Surges 14% Following Shift to Ethereum Treasury Strategy
Bit Digital Inc (NASDAQ:BTBT) shares jumped 14% after the cryptocurrency miner announced it had completed its transition to an Ethereum-focused treasury strategy, significantly boosting its ETH holdings. Following a recent underwritten public offering that raised about $172 million in gross proceeds, the company purchased approximately 100,603 ETH. Bit Digital also sold around 280 BTC to…
-
IonQ Shares Climb 6% After $1 Billion Equity Offering at Premium
IonQ, Inc. (NYSE:IONQ) stock rose 6% on Monday following the announcement of a $1.0 billion equity offering priced above the company’s recent share price. The quantum computing company set the offering price at $55.49 per share, approximately 25% higher than IonQ’s closing price on July 3. The deal includes 14,165,708 common shares and pre-funded warrants…
-
Mustang Bio Shares Surge After FDA Grants Orphan Drug Status
Mustang Bio Inc (NASDAQ:MBIO) stock soared over 78% following the U.S. Food and Drug Administration’s orphan drug designation for its MB-101 therapy targeting recurrent diffuse and anaplastic astrocytoma and glioblastoma—rare and aggressive brain cancers. The designation offers Mustang Bio benefits such as clinical trial tax credits and seven years of market exclusivity upon approval. The…